Cancer Genetics, Inc. And Roche Announce Expanded, Exclusive International Agreement To Provide Molecular Diagnostic Cancer Testing

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RUTHERFORD, N.J., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based diagnostics, and Roche Servicios S.A., an affiliate of Swiss drug maker Roche, have entered into an exclusive multi-year agreement to expand molecular diagnostic cancer testing in Central America and the Caribbean.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC